Overall, the immune modulation schemes surrounding immune checkpoints, DAMPs, and inflammasomes provide a more refined intervention approach for PCDimmune microenvironmentCOPD than simple PCD inhibition: On one hand, locally enhancing the PD-1/PD-L1 axis may reshape the toleranceinflammation balance without significantly increasing the risk of irAEs
Its plasma levels are determined by the rate of production and underlying inflammation severity
Such monitoring may include assessment of dietary protein intake, body composition trajectories, and micronutrient status in order to maintain proportionality between oxidative metabolic demand and substrate-supported regenerative capacity This perspective aligns with emerging calls to integrate pharmacologic and nutritional paradigms in obesity treatment, recognizing that durable metabolic adaptation requires coordination between drug-mediated signaling effects and substrate-dependent metabolic processes [103, 115]
The goal is to recognize those biological changes that underlie aberrant epigenetic programming of brain plasticity, and to recognize mitochondrial signaling pathways, metabolic factors, transcriptomic profiles and structural changes that indicate flexible adaptability or the lack thereof